BioSpace News Archive

Laura Kuri Benavides named new Director of Sustainability to lead IBC’s sustainability initiatives

Life Spine announced that it would be showcasing its complete line up of Micro Invasive procedural solutions, which includes 13 Expandable Interbody devices making it one of the largest and most innovative portfolios within the spine fusion market, at the 36th annual meeting of the North American Spine Society in Boston from September 29 through October 1, 2021.

GE Healthcare unveiled Revolution Ascendvi with Effortless Workflow, offering clinicians a collection of artificial intelligence technologies that automate and simplify time-consuming tasks to increase operational efficiency and free up time for clinicians to deliver more personalized care to more patients.

RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting at the Sidoti & Company Fall 2021 Conference

Radialogica LLC and ScientificRT GmbH announced they are collaborating with IRCCS Sacro Cuore-Don Calabria Cancer Care Center in Negrar, Verona, Italy, to define requirements and validate support for Elekta’s Unity treatment machine in Radialogica’s SciMoCa® plan QA software.

InnovAge Holding Corp. (the “Company” or “InnovAge”) (Nasdaq: INNV), a market leading healthcare delivery platform for high-cost, dual-eligible seniors, announced financial results for its fiscal fourth quarter and full year ended June 30, 2021.

Pulmonx Corporation, a global leader in minimally invasive treatments for severe lung disease, announced that Blue Cross Blue Shield Michigan and Horizon BCBS have issued positive coverage policies for endobronchial valves, such as the Zephyr® Endobronchial Valve, for severe emphysema, a form of COPD.

Hancock Jaffe Laboratories, Inc., a medical device company focused on improving the standard of care in the treatment of venous disease, announced a corporate update which includes a planned corporate rebranding and strategic prioritization of the Company’s development pipeline.

Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that Company representatives will be presenting at the 5th Advances in Circulating Tumor Cells (ACTC) conference in Kalamata, Greece, held on September 22-25, 2021.

Eli Lilly and Company (NYSE: LLY) announced today the pricing terms of its previously announced cash tender offer for specified series of its outstanding debt securities.